Efficacy News and Research

RSS
Researchers test plants used in traditional African medicine against malaria

Researchers test plants used in traditional African medicine against malaria

Bayer, Regeneron initiate two VEGF Trap-Eye Phase 3 trials in Diabetic Macular Edema

Bayer, Regeneron initiate two VEGF Trap-Eye Phase 3 trials in Diabetic Macular Edema

Targacept's TC-5619 Phase 2 trial data in schizophrenia presented at ICOSR

Targacept's TC-5619 Phase 2 trial data in schizophrenia presented at ICOSR

AJG publishes new review on Inflammatory Bowel Disease management

AJG publishes new review on Inflammatory Bowel Disease management

Johns Hopkins patient safety expert: Unreliable "outcomes" measures hamper efforts to assure better, safer care

Johns Hopkins patient safety expert: Unreliable "outcomes" measures hamper efforts to assure better, safer care

Genzyme's alemtuzumab Phase 2 trial data in MS to be presented at AAN meeting

Genzyme's alemtuzumab Phase 2 trial data in MS to be presented at AAN meeting

Positive top-line results from Roche's T-DM1 Phase II trial in HER2-positive MBC

Positive top-line results from Roche's T-DM1 Phase II trial in HER2-positive MBC

MAP Pharma publishes LEVADEX Phase 3 FREEDOM-301 study data in 'Headache' journal

MAP Pharma publishes LEVADEX Phase 3 FREEDOM-301 study data in 'Headache' journal

Supplements are less well regulated than drugs and may have side effects, drug interactions and toxicities

Supplements are less well regulated than drugs and may have side effects, drug interactions and toxicities

NIH awards HemoShear with Phase I SBIR grant to develop rodent liver system

NIH awards HemoShear with Phase I SBIR grant to develop rodent liver system

Circadian's VGX-100 neutralises VEGF-C and inhibits tumour growth in mouse models of human cancers

Circadian's VGX-100 neutralises VEGF-C and inhibits tumour growth in mouse models of human cancers

FDA approves Horizant Extended-Release Tablets for Restless Legs Syndrome

FDA approves Horizant Extended-Release Tablets for Restless Legs Syndrome

VBL's VB-111 preclinical data against metastatic cancer presented at AACR meeting

VBL's VB-111 preclinical data against metastatic cancer presented at AACR meeting

FDA approves Covidien's PMA application for Pipeline Embolization Device

FDA approves Covidien's PMA application for Pipeline Embolization Device

Superbugs and antibiotic resistance

Superbugs and antibiotic resistance

Record number of medicines for various cancers in clinical trials

Record number of medicines for various cancers in clinical trials

Celldex presents CDX-1127 preclinical data against cancer at AACR meeting

Celldex presents CDX-1127 preclinical data against cancer at AACR meeting

J&JPRD announces rivaroxaban Phase 3 trial results against venous thromboembolism

J&JPRD announces rivaroxaban Phase 3 trial results against venous thromboembolism

Neurocrine completes NBI-98854 Phase IIa study in schizophrenia patients with dyskinesia

Neurocrine completes NBI-98854 Phase IIa study in schizophrenia patients with dyskinesia

Caliper's CDAS unit enters cancer research collaboration with Denver-based CHI

Caliper's CDAS unit enters cancer research collaboration with Denver-based CHI

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.